Citations

Showing 10 of 108104 citations.

Hepatic artery stenosis after liver transplant: Donation after cardiac death donor vs donation after brain death donor grafts
Lee, David D. , Paz‐Fumagalli, Ricardo , Croome, Kristopher P. , Paz, D., Wright, Lauren , Nguyen, Justin H. , Paz, Diego, Taner, C. Burcin , Croome, Kris P , Lee, David D , Wright, Lauren

Mayo Clinic

Clinical Transplantation | September 22, 2018 | Volume: 32 | Issue: 11 | Pages: No page available

10.1111/ctr.13413 | PMID 30240491 Get It

AbstractBackgroundHepatic artery stenosis (HAS) after liver transplant (LT) is a source of significant morbidity. Some reports have suggested higher arterial complications in patients who receive donation after cardiac death (DCD) livers.MethodsA total of 2860 consecutive LT were reviewed from a prospectively collected database. All angiograms performed in LT recipients were reviewed and primary patency rates determined by need for further intervention or graft loss due to HAT.ResultsHepatic artery stenosis was seen in 4.6% of DCD and donation after brain death (DBD) recipients. Recipient male gender, age at transplant, complex donor hepatic artery anatomy, and prolonged operative time were all associated with HAS, but not DCD status. While HAS in recipients of DCD grafts required more stents (1.7% vs 0.6%, P = 0.04) and had worse primary patency rates (logrank, P = 0.02), outcomes as defined by HAT, patient and graft survival were not significantly different between the recipients of DCD or DBD grafts.ConclusionWe observed no significant difference in the incidence of hepatic artery complications, patient survival, or graft survival in recipients of DCD or DBD grafts. However, HAS in DCD recipients had worse primary patency and a higher need for stent placement.
Functional outcome and survival following spontaneous intracerebral hemorrhage: A retrospective population‐based study
Øie, Lise Rystad , Madsbu, Mattis A. , Solheim, Ole , Jakola, Asgeir Store , Giannadakis, Charalampis, Vorhaug, Anders, Padayachy, Llewellyn , Jensberg, Heidi, Salvesen, Øyvind , Gulati, Sasha , Øie, Lise R , Dodick, David, Dodick, David W.

Mayo Clinic

Brain and Behavior | September 22, 2018 | Volume: 8 | Issue: 10 | Pages: No page available

10.1002/brb3.1113 | PMID 30240164 Get It

AbstractBackgroundAccurate and reliable clinical and radiological predictors of intracerebral hemorrhage (ICH) outcomes are needed to optimize treatment of ICH. The aim of this study was to investigate functional outcome and identify predictors of severe disability or death following ICH.Materials and methodsRetrospective population‐based study of spontaneous ICH. Clinical and radiological data were obtained from electronic medical records, and functional outcome estimated using the modified Rankin Scale (mRS) before ICH and at 3 and 12 months after ICH.ResultsFour hundred and fifty‐two patients were included (mean age 74.8 years, 45.6% females). Proportion of fatal outcome at 1 week was 22.1%, at 3 months 39.2%, and at 12 months 44.9%. Median mRS score before the ICH was 1 (interquartile range [IQR] 2); for survivors at 3 months, it was 5 (IQR 3); and at 12 months, it was 3 (IQR 2). Independent predictors of severe disability (mRS of 5) or death (mRS of 6) were use of oral antithrombotic drugs (OR 2.2, 95% CI 1.3–3.8, p = 0.04), mRS score before the ICH (OR 1.8, 95% CI 1.4–2.2, p < 0.001), Glasgow Coma Scale (GCS) on admission (OR 8.3, 95% CI 3.5–19.7, p < 0.001), hematoma volume >60 ml (OR 4.5, 05% CI 2.0–10.2, p < 0.001), and intraventricular hematoma extension (OR 1.8, 95% CI 0.8–4.2, p < 0.001).ConclusionIntracerebral hemorrhage is associated with high mortality, and more than one third of survivors end up with severe disability or death 3 months later. Predictors of severe disability or death were use of oral antithrombotic drugs, functional disability prior to ICH, low GCS on admission, larger hematoma volume, and intraventricular hematoma extension.
Cerebrospinal fluid biomarkers predict frontotemporal dementia trajectory
Ljubenkov, Peter A. , Staffaroni, Adam M. , Allen, Isabel Elaine , Heuer, Hilary W. , Karydas, Anna, Kornak, John , Grinberg, Lea T. , Fagan, Anne M. , Jerome, Gina, Kramer, Joel H. , Miller, Bruce L. , Boxer, Adam L. , Rosen, Howard J. , Boeve, Brad F, Miller, Bruce L , Grinberg, Lea , Rojas, Julio C. , Wang, Ping , Cobigo, Yann , Seeley, William W. , Spina, Salvatore , Knopman, David S. , Boeve, Bradley F. , Dickerson, Bradford Clark

Mayo Clinic

Annals of Clinical and Translational Neurology | September 21, 2018 | Volume: 5 | Issue: 10 | Pages: 1250-1263

10.1002/acn3.643 | PMID 30349860 Get It

AbstractObjectiveThe prognostic value of cerebrospinal fluid neurofilament light chain, total tau, phosphorylated tau181, and amyloid beta1‐42was examined in frontotemporal dementia subtypes.MethodsWe compared baseline biomarkers between 49 controls, 40 patients with behavioral variant frontotemporal dementia, 24 with semantic variant primary progressive aphasia, and 26 with nonfluent variant primary progressive aphasia. Linear mixed effect models were used to assess the value of baseline biomarkers in predicting clinical and radiographic change in patient cohorts over multiple yearly follow up visits.ResultsNeurofilament light chain concentrations were lowest in controls. Elevated baseline neurofilament light chain predicted faster worsening in clinical severity, frontotemporal volume and frontotemporal fractional anisotropy in patients with behavioral variant frontotemporal dementia and nonfluent variant primary progressive aphasia. High total tau similarly predicted faster progression in nonfluent variant primary progressive aphasia. In behavioral variant frontotemporal dementia, higher phosphorylated tau181predicted faster clinical progression whereas lower amyloid beta1‐42predicted faster volumetric and fractional anisotropy reduction. Neurofilament light chain and phosphorylated tau181were of greater predictive value in patients with tau pathology as compared toTDP‐43 pathology. Baseline neurofilament light chain correlated with baseline clinical severity and frontotemporal volume in behavioral variant frontotemporal dementia. Baseline total tau correlated with baseline clinical severity in semantic variant primary progressive aphasia.InterpretationHigh cerebrospinal fluid neurofilament light chain predicts more aggressive disease in behavioral variant frontotemporal dementia and nonfluent variant primary progressive aphasia. Total tau, phosphorylated tau181, and amyloid beta1‐42also predict some measures of disease aggressiveness in frontotemporal dementia.
Genetic Abnormalities in Complement Regulating Proteins in C3 Glomerulopathy
Smith, Richard J H, Bu, Fengxiao , Borsa, Nicolò Ghiringhelli , Jones, Michael, Bierer, Amanda O., Meyer, Nicole C. , Frees, Kathy, Weaver, Amy , Sethi, Sanjeev , Ravindran, Aishwarya , Smith, Richard J H, Fervenza, Fernando C. , Zhang, Yuzhou , Jones, Michael, Weaver, Amy, Nester, Carla

Mayo Clinic

American Journal of Clinical Pathology | September 21, 2018 | Volume: 150 | Issue: suppl_1 | Pages: S131-S131

10.1093/ajcp/aqy102.313 Get It

Application of a Convolutional Neural Network to Distinguish Burkitt Lymphoma From Diffuse Large B-Cell Lymphoma
Mohlman, Jeffrey S., Leventhal, Samuel , Venkat, Aniketh, Gyulassy, Attila , Pascucci, Valerio , Salama, Mohamed Helmy , Salama, Mohamed

Mayo Clinic

American Journal of Clinical Pathology | September 21, 2018 | Volume: 150 | Issue: suppl_1 | Pages: S119-S119

10.1093/ajcp/aqy099.286 Get It

Automated Extraction of Microbial DNA From Formalin-Fixed, Paraffin-Embedded Tissue Using the Siemens Tissue Preparation System
Thorvilson, Jill N., Berry, Jonathan, Buckwalter, Seanne P., Lynne, Sloan, Rucinski, Stefanea L., Koelsch, Jolene M. , Pritt, Bobbi S. , Wengenack, Nancy L. , Pritt, Bobbi S , Saadalla, Abdulrahman , Schuetz, Audrey N.

Mayo Clinic

American Journal of Clinical Pathology | September 21, 2018 | Volume: 150 | Issue: suppl_1 | Pages: S151-S152

10.1093/ajcp/aqy112.357 Get It

Use of Mate-Pair Sequencing (MPseq) to Elucidate a Complex BCR-ABL1 Rearrangement Observed in a Newly Diagnosed Case of Chronic Myeloid Leukemia
Aguirre, Jose Jara, Hoppman, Nicole L., Vasmatzis, George , Smadbeck, James B. , Johnson, Sarah H. , Smoley, Stephanie A., Pitel, Beth A. , Pitel, Beth A , Baughn, Linda B. , Greipp, Patricia T. , Ketterling, Rhett P. , Peterson, Jess F.

Mayo Clinic

American Journal of Clinical Pathology | September 21, 2018 | Volume: 150 | Issue: suppl_1 | Pages: S131-S132

10.1093/ajcp/aqy102.314 Get It

A 10-Year Review of KMT2A Gene Fusion Partners Observed in Pediatric T-Lymphoblastic Leukemia/Lymphoma: The Mayo Clinic Experience
Peterson, J.L., Pearce, Kathryn E., Meyer, Reid G., Peterson, Jess, Baughn, Linda B. , Greipp, Patricia T. , Ketterling, Rhett P.

Mayo Clinic

American Journal of Clinical Pathology | September 21, 2018 | Volume: 150 | Issue: suppl_1 | Pages: S132-S132

10.1093/ajcp/aqy102.315 Get It

Sigma-1 receptor and amyotrophic lateral sclerosis
Benarroch, Eduardo E.

Mayo Clinic

Neurology | September 21, 2018 | Volume: 91 | Issue: 16 | Pages: 743-747

10.1212/wnl.0000000000006347 | PMID 30242016 Get It

Deep Learning and Online Video: Advances in Transcription, Automated Indexing, and Manipulation
Hoy, Matthew B.

Mayo Clinic

Medical Reference Services Quarterly | September 21, 2018 | Volume: 37 | Issue: 3 | Pages: 300-305

10.1080/02763869.2018.1477718 | PMID 30239300 Get It